To purchase three (3) 120 CNS kits to be measured on the Alamar Nulisa platform

This RFQ (75N95025Q04811V2) is a combined synopsis/solicitation for the purchase of three (3) Alamar Biosciences NULISAseq CNS Disease Panel 120 Kits (Catalog 800104) for the National Institute on Aging (NIA). The acquisition is a brand-name only requirement due to the kits' unique ability to simultaneously profile 120 CNS proteins from 10 microliters of plasma or CSF, compatibility with NULISA Technology and ARGO HT System, and specific protein markers included. Offers will be evaluated based on technical capability (pass/fail) and price, with technical capability and past performance weighted more heavily than price. The response deadline is September 18, 2025, at 2:00 PM EST. Responses must include unit price, list price, shipping and handling costs, delivery timeframe, payment discount terms, F.O.B. point, product/catalog numbers, product description, and relevant information demonstrating the offered item meets the specified salient characteristics. Offerors must be registered in SAM and submit completed FAR clauses 52.204-24 and 52.204-26. The successful offeror will be notified via a written notice of award.

Notice ID

e7aa0b4850174e63b188db66b676ccd9

Solicitation Number

75N95025Q04811V2

NAICS Code

334516

Classification Code

6640